Cordran Cream
NDC Package 74157-130-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cordran (flurandrenolide) cream is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). This formulation utilizes a cream delivery system. Marketed by Ina Pharmaceutics, Inc, this product is identified by NDC 74157-130 and is authorized under FDA application NDA012806.

Identification & Billing

NDC Package Code
74157-130-07
Package Description
1 TUBE in 1 CARTON / 120 g in 1 TUBE
Product Code
74157-130
11-Digit Billing Format
74157013007
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cordran
Non-Proprietary Name
Flurandrenolide
Substance Name
Flurandrenolide
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
FLURANDRENOLIDE .5 mg/g
Pharmacologic Class
Usage Information
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Flurandrenolide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid. The tape acts to protect the treated skin and makes the medication more effective and longer-lasting.

Regulatory & Marketing

Labeler Name
Ina Pharmaceutics, Inc
Product Type
Human Prescription Drug
FDA Application #
NDA012806
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-07-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 74157-130-07 identifies a specific commercial package of 1 tube in 1 carton / 120 g in 1 tube of Cordran, a human prescription drug labeled by Ina Pharmaceutics, Inc. This cream is formulated for topical use and contains flurandrenolide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ina Pharmaceutics, Inc on July 07, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Flurandrenolide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid. The tape acts to protect the treated skin and makes the medication more effective and longer-lasting.

How is this Ina Pharmaceutics, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 74157013007. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
74157-130-07
11-Digit CMS (5-4-2)
74157-0130-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.